NEW YORK, NY / ACCESS Newswire / June 8, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:

You might also be interested in reading Paramedic who survived Israeli attack that killed 15 aid workers describes alleged torture in custody.